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ABSTRACT
Background. Sentinel node biopsy (SNB) is an estab-
lished method in oral squamous cell carcinoma (OSCC) for
staging the cN0 neck and to select patients who will benefit
from a neck dissection. Near-infrared fluorescence (NIRF)
imaging has the potential to improve the SNB procedure by
facilitating intraoperative visual identification of the sen-
tinel lymph node (SN). The purpose of this study was to
evaluate the feasibility of fluorescence tracer imaging for
SN detection in conjunction with conventional radio-gui-
ded technique.
Methods. Prospective study of patients with primary
OSCC planned for tumor resection and SNB. Thirty
patients were injected peritumorally with a bimodal tracer
(ICG-99mTc-Nanocoll) followed by lymphoscintigraphy
and SPECT/CT to define the SNs and their anatomical
location preoperatively. SNs were detected intraoperatively
with a hand-held gamma-probe and a hand-held NIRF
camera.
Results. In 29 of 30 subjects (97%), all preoperatively
defined SNs could be identified intraoperatively using a
combination of radioactive and fluorescence guidance. A
total of 94 SNs (mean 3, range 1–5) that were both
radioactive and fluorescent ex vivo were harvested. Eleven
of 94 SNs (12%) could only be identified in vivo using
NIRF imaging, and the majority of those were located in
level 1 close to the primary tumor.
Conclusions. A combined fluorescent and radioactive
tracer for SNB is feasible, and the additional use of NIRF
imaging may improve the accuracy of SN identification in
oral cancer patients. Intraoperative fluorescence guidance
seems of particular value when SNs are located in close
proximity to the injection site.
In head and neck cancer, the presence of metastasis in the
tumor draining lymph nodes in the neck is one of the most
important prognostic factors for treatment outcome.1,2 Sen-
tinel node biopsy (SNB) is gaining acceptance in oral
squamous cell carcinoma (OSCC) and has been applied as a
standard staging method for the cN0 neck since 2007 in our
center.3 Approximately 20–30 % of patients presenting with
a cN0 neck harbor subclinical (occult) lymph node metas-
tases and can be identified using SNB, whereas the remaining
majority of patients can be spared an unnecessary selective
neck dissection and the associated morbidities.4,5 A recent
meta-analysis of SNB for early OSCC comprising 987
patients showed a sensitivity and negative predictive value of
86 and 94 %, respectively.6 The accuracy of conventional
radiocolloid-based SNB depends heavily on the ability to
correctly identify the true SN intraoperatively guided by a
radioactive signal combined with information from preop-
erative lymphoscintigraphy imaging. Radioactivity is
characterized by high tissue penetration but limited spatial
resolution, which may affect the accuracy of the intraoper-
ative navigation towards the SN. In particular when the SN is
located in close proximity to the injection site where back-
ground radioactivity is high, navigation can be difficult or
even impossible. In the setting of OSCC, this problem is
especially the case for SNs located in level 1 due to complex
drainage and close spatial relation to the oral cavity.7 A lower
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accuracy of the SNB procedure for tumors located in the floor
of the mouth (FOM) has been reported in recent larger series,
which may be explained by masking of the SN due to
radioactive shine-through from the injection site.8–10 Near-
infrared fluorescence (NIRF)-guided SNB is a novel
modality that enables real time intraoperative imaging of the
lymphatics within the surgical field with high spatial
resolution.11,12
The utility of Indocyanine Green (ICG) for SN mapping
has been studied in multiple malignancies suited for the
SNB procedure and most comprehensively in breast can-
cer.13–15 Recently, a bimodal approach has been introduced
for SNB by exploiting the beneficial hydrodynamic draining
properties of radiocolloids and the high affinity of ICG for
albumin, thereby assembling a combined tracer complex,
which is both fluorescent and radioactive.16 With a bimodal
tracer the preoperative radioactivity-based imaging and
surgical planning can be directly combined with the intra-
operative detection of the SN with both a visible fluorescent
signal and the conventional radioactive (acoustic) signal
available for navigation.17 Accordingly, adding NIRF
imaging to the SNB procedure has the potential to improve
the accuracy of intraoperative SN detection in OSCC.
The purpose of this study was therefore to evaluate the
feasibility of NIRF imaging for SN detection in early oral
cancer in conjunction with conventional radioguided
technique.
PATIENTS AND METHODS
Between December 2013 and September 2014, 30
patients diagnosed consecutively with primary cN0 T1-T2
OSCC and scheduled for tumor resection and SNB were
included in the study. In all the patients, the nodal neck
status was evaluated with clinical examination, ultrasound,
CT, and/or MRI. Exclusion criteria were prior head and
neck cancer, prior surgery or radiotherapy to neck, preg-
nancy, severe kidney failure, and allergy to ICG or iodine.
Patients were enrolled after obtaining informed consent.
The first author (AC) assisted in all the operations. The
study protocol was conducted in accordance with the
Helsinki Declaration and approved by the Danish Regional
Scientific Ethical Committee (H-1-2013-091). The study
was approved as a single-institution clinical trial by the
European Medicines Agency (EudraCT No. 2013-003578-
28, www.clinicaltrialsregister.eu) and was monitored and
conducted in accordance with GCP standards.
Tracer Preparation and Administration
99mTc-Nanocoll was prepared by adding 2 GBq of
pertechnetate in 2 ml of saline to a vial of Nanocoll
containing 0.5 mg of human albumin colloid (GE Health-
care). The mixture was incubated for 30 min before use.
ICG was prepared by adding 5 ml of sterile water to a vial
containing 25 mg of dry compound (ICG-Pulsion, Pulsion
Medical, Germany) and further diluted to a 0.5 mg/ml of
ICG stock solution. Then, 0.1 ml of 99mTc-Nanocoll (55 or
110 MBq depending on same-day or day-before surgery)
and 0.1 ml of ICG stock solution was mixed to a final
volume of 0.2 ml of ICG-99mTc-Nanocoll containing
0.05 mg of ICG (0.32 mM). The tracer was injected sub-
mucosally in four peritumoral deposits.
Preoperative Imaging
Lymphoscintigraphy (LSG) and SPECT/CT were per-
formed using a dual head SPECT/CT camera (Precedence
SPECT/CT, Philips Healthcare, The Netherlands) in a 60-
min scanning protocol. Immediately after tracer injection, a
dynamic LSG in anterior and lateral projection was
acquired followed by a static LSG 15 min postinjection to
identify the temporal order of SN identification. Then,
SPECT/CT was performed and images were generated. If
the first scanning session did not identify any SN, a second
late LSG and SPECT/CT was performed 120 min postin-
jection. Images were interpreted by a specialist in nuclear
medicine, and the localization of the SN was depicted in an
anatomical chart of the neck divided into neck levels as
proposed by AHNS.18 The number of SNs detected on LSG
and SPECT/CT was recorded. A lymph node clearly visible
on LSG or SPECT/CT was considered a SN.
Surgical Procedure and Intraoperative Imaging
Tumor resection and reconstruction was done before the
SNB neck procedure. Fluorescence imaging was performed
with the clinically approved hand-held NIR camera system
and accompanying software (Fluobeam 800, Fluoptics,
France). Before skin incision, fluorescence imaging was
performed to localize SNs that were visible transcuta-
neously. During surgery, the NIR camera and a hand-held
gamma probe (Neo2000, Neoprope Corporation, USA)
were used in parallel to navigate towards the SN, and the
modality (radioactive and/or fluorescent) for identification
was recorded. To distinguish a SN from a non-SN, a
radioactive count rate less than 10 % of the SN with the
highest count rate was applied as a rule. In addition, any
lymph node with a bright fluorescent signal was appointed
a SN. Intraoperative fluorescence imaging of the SNs in the
in situ location was performed before removal, and the
exact anatomical location was recorded. The surgical field
was searched systematically for any remaining radioactive
or fluorescent signal before closure. Operation time for the
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SNB in the neck was defined as from skin incision to
completed skin closure.
Ex Vivo Imaging and Histology
The harvested SNs were postoperatively imaged with
the NIR camera under standardized conditions and aligned
beside a reference tube containing a 0.2-lM ICG solution.
Harvested SNs were fixed in formalin for 24 h, paraffin
embedded, and processed with step-serial sectioning, using
H&E staining and cytokeratin antibodies according to a
previously described protocol.4 Tumor deposits were
classified as macrometastasis, micrometastasis, or isolated
tumor cells.19 Non-SNs encountered during dissection that
not could be preserved and therefore resected were exam-
ined with routine histopathological analysis. Tissue
sections stained with H&E from a selected number of SNs
and non-SNs were imaged using a NIR scanner (Odyssey
Sa, LI-COR Biosciences, UK).
Data Analysis
For statistical analyses, SAS Enterprise software Ver-
sion 9.4 was used. A value of p\ 0.05 was considered
statistically significant. Continuous measures were com-
pared using Wilcoxon signed-rank test between groups. On
intraoperative and postoperative unsaturated raw grayscale
images the fluorescence signal was semiquantified using
regions of interest in the software ImageJ (version 1.48,
NIH, USA). A Signal-to-Background-Ratio (SBR) and
Signal-to-Reference-Ratio (SRR) was calculated by divid-
ing the fluorescent signal of the SN by the fluorescent
signal of adjacent tissue intraoperatively or the ICG-ref-
erence and standard background postoperatively.
RESULTS
Patient and tumor characteristics are outlined in Table 1.
All patients were managed with a transoral tumor resection
and a primary closure or a local flap. No adverse reactions
or complications related to the hybrid tracer were observed.
Six patients (20 %) had a single positive SN and a subse-
quent selective neck dissection was performed where no
additional metastatic deposits were found in the neck
specimens on routine histopathology.
Preoperative Imaging
A total of 68 SNs were defined preoperatively and
modality for detection is shown in Table 2. In two patients,
no SN was detected on the initial imaging and a late second
LSG and SPECT/CT was performed where a SN could be
detected in both cases. In 18 patients (60 %), bilateral
lymphatic drainage was seen, and 1 patient (3 %) with a
lateralized FOM tumor had only contralateral drainage.
TABLE 1 Patient and tumor characteristics
Characteristic N or mean % or range
Age, year (mean, range)
Men 64 (52–83)
Women 63 (50–79)
Body mass index (mean, range) 24.3 (18.0–32.3)
Tumor subsite location in oral cavity
Floor of mouth 15 50
Tongue, ant. 2/3 9 30
Inferior tongue 2 7
Buccal 1 3
Hard palate 1 3
Gingiva 1 3













Macrometastasis ([2 mm) 3 50
Micrometastasis (C0.2 mm, B2 mm) 3 50




TABLE 2 Modality for SN identification
Modality for SN identification N Detection rate % (n/n)
Preoperatively
Total no. of SNs visualized 68 71 (68/96)
LSG 41 43 (41/96)
SPECT/CT 68 71 (68/96)
Intraoperatively
Total no. of SNs harvested 94 98 (94/96)
Fluorescent ? radioactive 83 86 (83/96)
Radioactivity only 0 0 (0/96)
Fluorescence only 11 11 (11/96)
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Intraoperative Imaging and Lymph Node Detection
A total of 94 SNs were detected intraoperatively
yielding an average of 3 SNs (range 1–5) per patient; the
distribution in the neck is depicted in Table 3. At least one
SN was identified in all patients. In one patient with a FOM
tumor, two of three preoperatively defined SNs, with an
unusual location medial to the mandible within the FOM,
could not be located, and the neck procedure was extended
to a bilateral neck dissection after which the patient was
staged as pN0. Therefore, the intraoperative detection rate
of the preoperatively defined SNs was 97 % (66/68).
Before skin incision, 10 % (9/94) of the excised SNs could
be visualized by fluorescence transcutaneously (Fig. 1).
The success of noninvasive transcutaneous SN identifica-
tion was significantly correlated with a low BMI
(p = 0.05).
Intraoperatively, 11 SNs in 9 patients could only be
identified due to fluorescence. They were all located soli-
tary and not as a part of a cluster of lymph nodes and they
were not identified on SPECT/CT (Fig. 2). In seven of nine
of the patients, these additional nodes could be detected
through the incision made to search level 1 and/or level 2.
In two patients with FOM tumors, an additional incision
was made in the contralateral neck because transcutaneous
NIR imaging demonstrated drainage to level 1, and two
additional nodes could be retrieved. These additional SNs
were all negative on histology and therefore did not lead to
upstaging of patients. No SN was identified only due to the
radioactive signal. Ex vivo, all 94 harvested SNs were both
radioactive and fluorescent (Table 3). The mean intraop-
erative SBR of the SNs was 7.8 (range 1.9–30.6). Clusters
of 3–5 lymph nodes were often encountered in level 2a
where fluorescence enabled easy separation in SNs and
non-SNs due to real-time imaging. On micro-fluorescence
scanning of tissue slides of SNs and non-SNs anatomically
located closely adjacent in a cluster, the fluorescent signal
from ICG could be seen distributed within the lymphatic
drainage system in the SN while no fluorescent signal
could be detected in the non-SN (Fig. 2).
In the 23 patients, who had three or more SNs removed,
the fluorescence intensity, measured as SBR or SRR, cor-
related with the radioactive count both intraoperatively
(p = 0.015) and ex vivo (p = 0.007) when analyzed in a
mixed model. Within each patient, a linear correlation
between either intraoperative or ex vivo fluorescence
intensity and radioactivity was observed (Fig. 3).
DISCUSSION
To our knowledge, this prospective study is the largest
to date on fluorescence-guided SNB in OSCC. By adding
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additional 11 SNs were detected that otherwise would have
been left behind when using conventional radioguided
technique. Anatomically, the additional SNs were located
almost exclusively in level 1 close to the injection site in
the oral cavity and, therefore, demonstrate that intraoper-
ative fluorescence imaging enables navigation towards SNs
otherwise masked by the radioactive background signal.
These findings support a recent similar study of SN
detection in 14 N0 OSCC patients using ICG-99mTc-
Nanocoll.20 In addition, an added value of the SNB hybrid
tracer principle for melanoma in the head and neck region
has been reported.21
We found SPECT/CT superior to LSG in terms of pre-
operative SN detection, which previously has been reported
by our group and others.22,23 In addition, SPECT/CT pro-
vided very accurate anatomical information about SN
location useful for planning of surgery, and we recommend
SPECT/CT to be an integrated part of SNB procedures in
the head and neck region.
The yield of subclinical metastases was 20 %, which is
low compared with other series that reflect that 60 % were
T1 tumors with a lower risk of metastatic spread compared
with higher T-stage tumors. We observed a high percentage
(60 %) of bilateral drainage probably, because the majority
of the tumors in this cohort was in the FOM.
We observed an excellent retention of ICG-99mTc-
Nanocoll in the SN, even in patients injected the day before
the SNB procedure, while draining to second tier nodes
downstream was minimal. This probably reflects that the
hybrid tracer has the beneficial hydrodynamic characteris-
tics of Nanocoll for SN mapping.24 In addition, the strong
correlation between fluorescence intensity and radioactiv-
ity in the SNs within each patient in our study indicates that
the hybrid tracer complex remains stable in vivo. This is in
accordance with results reported by van der Poel et al. in
prostate cancer patients.25 For future studies, this obser-
vation also has the implication that only nodes that are both
fluorescent and radioactive after resection should be
regarded as true SNs.
NIRF-guided SNB mapping using unmixed ICG in oral
and oropharyngeal cancer has been reported in a few
studies where problems with rapid transportation of ICG to
higher echelon nodes were noted.26,27 When performing
NIRF-guided SNB in head and neck cancer patients, strong
tracer retention in the SN and minimal overflow to higher
echelon nodes is of paramount importance, which depends
FIG. 1 Preoperative and intraoperative SN imaging. LSG (a), axial
SPECT/CT (b), and the 3-D reconstructed SPECT/CT (c) in a patient
with a well-lateralized tumor on the right anterior tongue showing
tracer drainage to an ipsilateral SN in level 1 and directly to a
contralateral SN in level 3 (arrows). The latter SN in level 3 in the left
neck side was visible transcutaneously (e). The Fluobeam 800 NIR
camera (d) designed for ICG imaging. The NIR camera entered the
surgical field in a sterile cover, and real-time video imaging was
presented for the surgical team on a clinical screen. When using the
NIR camera intraoperatively, the direct surgical light was turned off
to improve the quality of the imaging. The system has a 750-nm
excitation laser and LED white light illumination of the surgical field
that does not inflict on the NIRF imaging. The hand-held camera head
is maneuverable in all angles and has a 910 zoom function. The
autofocus function allows for flexible working distance. Intraopera-
tive NIRF-guided identification and resection of SN (f, g, h)
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on the use of a carrier colloid. In breast cancer, the use of
unmixed ICG, which has a hydrodynamic diameter\1 nm,
has proven to be successful, because direct transcutaneous
dynamic visualization of the rapid tracer flow towards the
SN within minutes is possible.28 However, this is not the
case in the neck, and in our opinion initial radioguidance is
still required for lymphatic SN mapping in head and neck
cancer.
FIG. 2 Intraoperative SN identification by NIRF imaging only. The
exact anatomical location and neck level location in the ipsilateral (a)
and contralateral (b) neck side of the 11 additional SNs identified only
by fluorescence. H&E staining and fluorescence microimaging of a
tissue section from a SN (c and d) and a non-SN (e and f) located
intimately within the same cluster of lymph nodes in level 2a. None of
the lymph nodes contains metastatic tumor. In the SN the microan-
tomical distribution of the fluorescent tracer draining from the
marginal sinus towards the medullary sinus is visualized. The non-SN
is without any signal from ICG on NIRF microimaging
FIG. 3 Correlation between
the fluorescent and the
radioactive signal. A
representative case example (a)
of linear correlation between the
intraoperative fluorescent and
the radioactive signal in three
resected SNs from the same
patient. Postoperative NIRF
imaging (b) of the same three
SNs aligned besides a reference
tube containing a 0.2-lM ICG
concentration
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Similar to results by Crane et al. using unmixed ICG for
SNB in vulvar cancer, we found the transcutaneous fluores-
cence signal to be correlated to the BMI of the patient and that
transcutaneous node mapping was not feasible.29 The fluo-
rescent signal from ICG has a limited tissue penetration of
approximately 0.5–1.5 cm. Accordingly, in our study some
exploration in the surgical field was necessary in the majority
of cases to obtain successful NIRF imaging of the SN.
Clusters of closely located lymph nodes embedded in fatty
tissue in the neck are common, and in the present study NIRF
imaging enabled direct visual differentiation of SN from non-
SNs for selective dissection of the SN. In addition, often only
one of several lymph nodes within a cluster was the tumor
draining SN. This supports the SNB theory of timely ordered
and individual lymph node drainage patterns. By the NIRF
imaging approach, the risk of sending non-SNs for expensive
thorough SN pathology examination may be limited.
To prove an added value of NIRF-guided SNB in head
and neck cancer, future studies with follow-up data of N-
site recurrences in SN-negative patients are needed to
address the false-negative rate stratified for tumor subsites.
In conclusion, a combined fluorescent and radioactive
tracer approach for SNB is feasible and additional use of
NIRF imaging may improve the accuracy of SN identifi-
cation in OSCC. Intraoperative fluorescence guidance
seems of particular value when SNs are located in close
proximity to the injection site.
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